Regulations for radioiodine therapy in the United States: Current status and the process of change

Thyroid

Volumn 7, Issue 2, 1997, Pages 209-211

  Vetter, Richard J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; RADIATION INJURY; RADIATION PROTECTION; REVIEW; THYROID DISEASE; UNITED STATES;

EID: 0030890661     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.209     Document Type: Review

References (9)

1. International Commission on Radiological Protection 1991 Recommendations of the International Commission on Radiological Protection. Annals of the ICRP 21.ICRP Publication 60. ICRP, Oxford.
2. National Council on Radiation Protection and Measurements 1993 Limitation of exposure to ionizing radiation. NCRP Publication no. 116. NCRP, Bethesda, Maryland.
3. US Nuclear Regulatory Commission 1995 Medical use of byproduct material. Code of Federal Regulations Title 10, Part 35. NRC, Washington, DC.
4. US Nuclear Regulatory Commission 1995 Standards for protection against radiation. Code of Federal Regulations Title 10, Part 20. NRC, Washington, DC.
5. US Nuclear Regulatory Commission 1997 Criteria for release of individuals administered radioactive material. Federal Register 62:4120.
6. National Council on Radiation Protection and Measurements 1995 Dose limits for individuals who receive exposure from radionuclide therapy patients. NCRP Commentary no. 11. NCRP, Bethesda, Maryland.
7. US Nuclear Regulatory Commission 1993 ALARA levels for effluents from materials facilities. Regulatory Guide 8.37. NRC, Washington, DC.
8. National Council on Radiation Protection and Measurements 1987 Recommendations on limits for exposure to ionizing radiation. NCRP Report no. 91. NCRP, Bethesda, Maryland.
9. US Nuclear Regulatory Commission 1991 Standards for protection against radiation. Federal Register 56:23360.